Vocal Biomarkers in Cardiac Rhythm Management and Remote Patient Monitoring: EVOCAL Health discusses scientific findings

Hamburg (Germany), March 15, 2022: With the relentless rise of digital health, we are witnessing the emergence of digital biomarkers –...

Hamburg (Germany), March 4, 2022: The role of machine learning in the development of prognostic models for early warning systems and risk...

Hamburg (Germany)/ Vienna (Austria), March 1, 2022: The use of modern digital technology in pulmonary rehabilitation offers unprecedented...

Hamburg (Germany), February 24, 2022: Biomarkers are an integral part of biomedical research and clinical practice. As digital devices...

Hamburg (Germany), February 02, 2022: The evolution of voice technology in research and clinical practice, audio signal analysis, and...

Hamburg (Germany), December 21, 2021: Reimagining health in the home care environment will require patient centric and interconnected...

EVOCAL Health Releases Cloud-Based Vocal Biomarker Development Platform: SaaS-Platform To Leverage the Potential Of Human Voice Biomarkers

EVOCAL Health receives CE certification for its first commercial product with Vocal Biomarker technology.